How the Discovery of Penicillin Changed Medicine and Why Antibiotic Resistance Is a Growing Crisis

How the Discovery of Penicillin Changed Medicine and Why Antibiotic Resistance Is a Growing Crisis

In 1928, Alexander Fleming noticed that a mold contaminant on a petri dish had killed surrounding bacteria — an observation that would eventually save 200 million+ lives and launch the antibiotic era. Penicillin was the first true antibiotic, and it transformed medicine so completely that deaths from bacterial infections plummeted by 90% in developed countries. But nearly a century later, antibiotic resistance threatens to reverse these gains: the WHO estimates that drug-resistant infections could kill 10 million people per year by 2050 — more than cancer. The story of penicillin is simultaneously the greatest triumph and one of the greatest warnings in modern medicine.

The Discovery

• Date: September 1928, St. Mary's Hospital, London
• Discoverer: Alexander Fleming (Scottish bacteriologist)
• The observation: A petri dish of Staphylococcus bacteria was contaminated by Penicillium notatum mold; bacteria near the mold had been killed
• Fleming's conclusion: The mold produced a substance ("penicillin") that killed bacteria
• Crucial detail: Fleming was famously untidy — the petri dish was left uncovered during vacation, allowing mold to grow
• ** Fleming published in 1929 but didn't develop penicillin as a drug (he lacked biochemistry expertise)

From Discovery to Drug (1939-1944)

• 1939: Howard Florey, Ernst Chain, and Norman Heatley at Oxford began isolating and purifying penicillin
• 1940: First animal tests: Mice infected with lethal bacteria survived with penicillin treatment
• 1941: First human trials (at Oxford): Penicillin cured severe bacterial infections
• 1942: Mass production began in the US (in collaboration with Pfizer, Merck, and other companies)
• 1943: Penicillin production scaled up dramatically using deep-tank fermentation
• 1944: D-Day: Penicillin saved thousands of Allied soldiers from wound infections
• 1945: Fleming, Florey, and Chain awarded the Nobel Prize in Medicine

The Impact

Before antibiotics (pre-1940):

• Strep throat could lead to rheumatic fever → heart damage → death
• Pneumonia killed 30% of patients
• Tuberculosis killed 1 in 7 people in Europe and America
• Minor cuts and scratches could lead to fatal sepsis
• Childbirth fever killed 1 in 10 mothers
• Average life expectancy: ~47 years (US, 1900)

After antibiotics (post-1945):

• Strep throat: cured with 10 days of penicillin
• Pneumonia: cure rate >95% with antibiotics
• Tuberculosis: curable with antibiotic combinations (though MDR-TB is emerging)
• Minor infections: routine treatment with topical/oral antibiotics
• Childbirth fever: virtually eliminated in hospitals
• Average life expectancy: ~79 years (US, 2024) — antibiotics contributed ~10 years

Surgical revolution:

• Open-heart surgery, organ transplants, joint replacements, chemotherapy — ALL depend on antibiotics to prevent infections
• Without effective antibiotics: Most major surgeries become too risky to perform

The Antibiotic Resistance Crisis

What is it:

• Bacteria evolve resistance to antibiotics through mutation and horizontal gene transfer
• Overuse of antibiotics accelerates resistance (survival of the fittest bacteria)
• Resistant bacteria: MRSA, VRE, CRE, drug-resistant TB, drug-resistant gonorrhea

Scale of the problem:

• 700,000+ deaths per year from drug-resistant infections (current, 2024)
• 10 million deaths/year projected by 2050 (WHO estimate — more than cancer)
• $100 trillion in lost economic output by 2050 (World Bank)
• Last-resort antibiotic: Colistin — resistance to colistin has been found (mcr-1 gene, discovered 2015)

Causes:

• Overuse in human medicine: 30-50% of antibiotic prescriptions are unnecessary (viral infections, common cold)
• Agricultural use: 70%+ of antibiotics globally are used in livestock (growth promotion and disease prevention)
• Incomplete courses: Stopping antibiotics early allows partially-resistant bacteria to survive
• Hospital-acquired infections: Hospitals are breeding grounds for resistant bacteria
• Lack of new antibiotics: Only 12 new antibiotics approved 2017-2023 (vs 50+ in 1980s-1990s)

Why no new antibiotics:

• R&D costs $1-2 billion per new antibiotic
• Antibiotics are used for short courses (7-14 days) → lower revenue than chronic drugs
• Pharmaceutical companies prefer more profitable drug categories (oncology, CNS, diabetes)
• Antibiotic resistance develops within 1-2 years of introduction → short commercial lifespan
• Market failure: The drugs we need most are the least profitable to develop

What's Being Done

• AMR Action Fund: $1 billion fund to support antibiotic R&D (launched 2020)
• CARB-X: $500+ million program funding early-stage antibiotic development
• Pull incentives: Proposed subscription models where governments pay for antibiotic access regardless of usage (UK pilot, 2023)
• Diagnostic tests: Rapid tests to distinguish bacterial vs viral infections (reduce unnecessary prescribing)
• Phage therapy: Using viruses that kill bacteria (alternative to antibiotics, used in Georgia/Russia for decades)
• CRISPR-based approaches: Targeted elimination of resistant bacteria genes

Fun Facts

• Fleming's original petri dish is preserved at the Imperial College London museum
• Penicillin was nicknamed "the wonder drug" during WWII
• The first patient treated with penicillin (Albert Alexander, 1941) recovered but died when supply ran out
• Fleming predicted antibiotic resistance in his 1945 Nobel Prize acceptance speech
• Before penicillin, a paper cut could be a death sentence
• The "antibiotic" class includes penicillins, cephalosporins, tetracyclines, macrolides, fluoroquinolones, and aminoglycosides

The Takeaway

Penicillin — discovered accidentally in 1928 by an untidy bacteriologist — launched the antibiotic era that has saved 200+ million lives and added 10 years to average human lifespan. It transformed surgery, childbirth, and infectious disease treatment so completely that pre-antibiotic medicine is almost unimaginable. But antibiotic resistance threatens to reverse these gains: drug-resistant infections already kill 700,000+ people per year and could kill 10 million by 2050. The causes are overuse in human medicine and agriculture, incomplete treatment courses, and — critically — a market failure where the antibiotics we need most are the least profitable to develop. Without new antibiotics and better stewardship, we face a post-antibiotic future where minor infections are lethal, surgeries are too risky, and the medical progress of the past century begins to unravel. Fleming's 1945 warning was prophetic. The wonder drug is losing its power — and the consequences affect everyone.